Abstract:Abstract Immunotherapy has revolutionized cancer treatment with Immune checkpoint inhibitors (ICIs) and genetically engineered T-Cells expressing chimeric antigen receptors (CARs). CAR-T treatment of hematologic malignancies has achieved outstanding patient response rate. CAR T therapy, however, is thwarted in solid tumor treatment due to two major factors: the immune-suppressive tumor microenvironment that Inhibits T-cell infiltration and T-cell function. In addition, cancer resistance to ICIs treatment also limits the solid tumor response rate. This research aims to activate proinflammatory anticancer immune responses in immunologically cold solid tumors using the genetically engineered Salmonella typhimurium VNP20009 strains that express anticancer proteins. Previously, we have shown that the Salmonella Typhimurium VNP20009 strain expressing methioninase (METase) and/or Tumor Necrosis Factor (TNFα) caused rapid tumor destruction of cold Lewis Lung Carcinoma (LLC) grown on immunocompetent C57BL/6 mice. In this investigation, several mechanisms of this tumor tropic anti-cancer bacteria were studied including the innate and adaptive immune system responses and cancer cell apoptosis. In a pilot study, we selected eight tumor tissues treated with several different bacteria strains and performed histological analysis to observe the effectiveness of each. We found that in the tumor tissues treated with VNP20009_rMETase_TNFα, there was infiltration and activation of CD8+ T cells coupled with reduced amounts of T regulatory cells, as well as an increased ratio of M1-like to M2-like macrophages. We also observed increased tumor apoptosis associated with an elevated detection of an apoptosis biomarker and a suppressed amount of the Ki67 tumor growth signal. These findings indicate that VNP20009_rMETase_TNFα anticancer bacteria can disrupt the tumor microenvironment in the cold LLC tumors and active innate and adaptive anti-cancer immune response in immunocompetent mice. Further, we are investigating additional cold solid mouse tumor models to validate our findings and how this can apply to bacteria-based immunotherapy. Citation Format: Qiuhong He, Lindsay R. Brncick, Boxi Gong, Julia L. Flowers. M1-like macrophage infiltration, CD8+ T cell activation, and increased cancer cell apoptosis in immunologically cold Lewis lung carcinoma treated with tumor-trophic Salmonella Typhimurium expressing anticancer proteins in immunocompetent C57BL/6 mice [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2024; Part 1 (Regular Abstracts); 2024 Apr 5-10; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2024;84(6_Suppl):Abstract nr 184.

Abstract 2678: Traditional Chinese Medicine (TCM) in combination withS. typhimuriumA1-R for cancer treatment

Traditional Chinese Medicine (Tcm) Enhances Efficacy And Reduces Toxicity Of Tumor-Targeting S. Typhimurium A1-R In A Syngeneic Breast Cancer Metastatic Mouse Model

Salmonella typhimurium A1-R tumor targeting in immunocompetent mice is enhanced by a traditional Chinese medicine herbal mixture.

Tumor-Targeting Salmonella Typhimurium Improves Cyclophosphamide Chemotherapy At Maximum Tolerated Dose And Low-Dose Metronomic Regimens In A Murine Melanoma Model

A Primer Dose Followed By Low-Bolus Dose Schedule For Safe And Efficacious Bacterial Tumor Targeting With S. Typhimurium A1-R

Abstract 1691: A primer dose followed by low-bolus dose schedule of tumor-targeting ofS. typhimuriumA1-R is effective for tumor-targeted therapy

Abstract 5547: Oral delivery of tumor-targeting Salmonella typhimurium A1-R is effective therapeutically

Abstract 2802: Salmonella typhimurium A1-R inhibits brain metastasis in an orthotropic breast cancer nude-mouse model.

Tumor-Targeting Salmonella Typhimurium A1-R in Combination with Trastuzumab Eradicates HER-2-Positive Cervical Cancer Cells in Patient-Derived Mouse Models

Abstract 184: M1-like macrophage infiltration, CD8+ T cell activation, and increased cancer cell apoptosis in immunologically cold Lewis lung carcinoma treated with tumor-trophic Salmonella Typhimurium expressing anticancer proteins in immunocompetent C57BL/6 mice

Abstract 583: Treatment of human liver cancer in nude mice with a tumor-targeting<i>Salmonella typhimurium</i>auxotroph

Abstract 2804: Anti-tumor and Anti-Metastatic Efficacy of TCM on Prostate Cancer in Orthotopic Model of Metastatic Cancer.

Tumor‐Targeting Salmonella Typhimurium A1‐R Promotes Tumoricidal CD8+ T Cell Tumor Infiltration and Arrests Growth and Metastasis in a Syngeneic Pancreatic‐Cancer Orthotopic Mouse Model

Toxicology and Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R Compared to VNP 20009 in a Syngeneic Mouse Tumor Model in Immunocompetent Mice

Tumor-Targeting Salmonella Typhimurium A1-R Efficacy On Colon Cancer Liver Metastasis Alone And In Combination With Fluorescence-Guided Surgery

Therapeutic Efficacy of Tumor-Targeting Salmonella Typhimurium A1-R on Human Colorectal Cancer Liver Metastasis in Orthotopic Nude-Mouse Models.

Abstract 579: Chinese Herbal Mixture LQ Inhibits Tumor Growth and Metastasis and Increases Survival in Orthotopic and Other Mouse Models of Human and Mouse Cancer

Radiotherapy Combined with an Engineered Salmonella Typhimurium Inhibits Tumor Growth in a Mouse Model of Colon Cancer.

Tumor-Targeting Salmonella Typhimurium A1-R Promotes Cd8+T Cell Infiltration In Pancreatic Cancer In An Orthotopic Syngeneic Mouse Model

Abstract 3311: In vivo selection of S. typhimurium A1-R enhanced tumor-targeting variants.

Efficacy Against Lung Metastasis with a Tumor-Targeting Mutant of Salmonella Typhimurium in Immunocompetent Mice.